Activities, Bill Numbers and Titles
|
|
Client: Pfizer Inc.
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $2,530.50
|
House Bill
|
5159
|
An Act enhancing the market review process.
|
Support
|
$0.00
|
N/A
|
House Bill
|
4653
|
An Act enhancing the market review process
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
3012
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
1458
|
An Act to enhance the rights of crime victims in the Commonwealth
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1142
|
An Act to prohibit cost sharing for opioid antagonists
|
Support
|
$0.00
|
N/A
|
House Bill
|
2149
|
An Act to ensure safe medication administration
|
Support
|
$0.00
|
N/A
|
House Bill
|
4411
|
An Act relating to patient cost, benefit and coverage information, choice, and price transparency
|
Oppose
|
$0.00
|
N/A
|
| | |
Total amount
|
$0.00
| |
|
|
|
Meals, Travel, and Entertainment Expenses
|
No meals, travel, or entertainment expenses were filed for this disclosure reporting period. |
|
|
Additional Expenses
|
No additional expenses were filed for this disclosure reporting period. |
|
|
Campaign Contributions
|
No campaign contributions were filed for this disclosure reporting period. |
|